In a pivotal study investigating the association of LOY with adverse outcomes in bladder cancer, TCGA data analysis demonstrated that patients with reduced expression of Y chromosome-encoded genes (e.g., KDM5D and UTY also known as KDM6C) exhibited shorter survival, with LOY detectable even in early-stage malignancies (29). The gene discussed is UTY; the disease is urinary bladder cancer.